SCM
Scopia Capital Management’s United Therapeutics UTHR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-269,455
| Closed | -$48.3M | – | 18 |
|
|
2021
Q2 | $48.3M | Buy |
269,455
+60,170
| +29% | +$10.8M | 6.56% | 7 |
|
|
2021
Q1 | $35M | Buy |
209,285
+3,759
| +2% | +$629K | 4.34% | 8 |
|
|
2020
Q4 | $31.2M | Buy |
+205,526
| New | +$31.2M | 3.95% | 9 |
|
|
2017
Q3 | – | Sell |
-705,003
| Closed | -$91.5M | – | 39 |
|
|
2017
Q2 | $91.5M | Sell |
705,003
-1,668,184
| -70% | -$216M | 1.89% | 22 |
|
|
2017
Q1 | $321M | Sell |
2,373,187
-875,682
| -27% | -$119M | 5.93% | 5 |
|
|
2016
Q4 | $466M | Sell |
3,248,869
-843,832
| -21% | -$121M | 8.83% | 3 |
|
|
2016
Q3 | $483M | Sell |
4,092,701
-208,651
| -5% | -$24.6M | 8.52% | 2 |
|
|
2016
Q2 | $456M | Buy |
4,301,352
+82,071
| +2% | +$8.69M | 9.41% | 2 |
|
|
2016
Q1 | $470M | Buy |
4,219,281
+1,370,698
| +48% | +$153M | 8.77% | 2 |
|
|
2015
Q4 | $446M | Buy |
2,848,583
+2,714
| +0.1% | +$425K | 8.85% | 2 |
|
|
2015
Q3 | $373M | Buy |
2,845,869
+734,960
| +35% | +$96.5M | 8.01% | 3 |
|
|
2015
Q2 | $367M | Sell |
2,110,909
-304,777
| -13% | -$53M | 7.13% | 3 |
|
|
2015
Q1 | $417M | Sell |
2,415,686
-541,804
| -18% | -$93.4M | 9.01% | 2 |
|
|
2014
Q4 | $383M | Buy |
2,957,490
+323,001
| +12% | +$41.8M | 7.13% | 2 |
|
|
2014
Q3 | $339M | Buy |
2,634,489
+2,029,567
| +336% | +$261M | 6.91% | 2 |
|
|
2014
Q2 | $53.5M | Buy |
+604,922
| New | +$53.5M | 1.38% | 15 |
|